位置:首页 > 蛋白库 > 3L21_LATSE
3L21_LATSE
ID   3L21_LATSE              Reviewed;          87 AA.
AC   P01379; O93496; Q7T2I4;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   15-NOV-2002, sequence version 2.
DT   25-MAY-2022, entry version 121.
DE   RecName: Full=Alpha-elapitoxin-Ls2a;
DE            Short=Alpha-EPTX-Ls2a;
DE   AltName: Full=Long neurotoxin Ls3;
DE   AltName: Full=LsIII {ECO:0000303|PubMed:4616684, ECO:0000303|PubMed:8555211};
DE            Short=Ls III {ECO:0000303|PubMed:26221036};
DE   AltName: Full=Neurotoxin 1;
DE   AltName: Full=Neurotoxin alpha;
DE   Flags: Precursor;
OS   Laticauda semifasciata (Black-banded sea krait) (Pseudolaticauda
OS   semifasciata).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Lepidosauria; Squamata; Bifurcata; Unidentata; Episquamata; Toxicofera;
OC   Serpentes; Colubroidea; Elapidae; Laticaudinae; Laticauda.
OX   NCBI_TaxID=8631;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT LSIII-5 LYS-40.
RC   TISSUE=Venom gland;
RX   PubMed=9920490; DOI=10.1016/s0041-0101(98)00181-0;
RA   Tamiya T., Ohno S., Nishimura E., Fujimi T.J., Tsuchiya T.;
RT   "Complete nucleotide sequences of cDNAs encoding long chain alpha-
RT   neurotoxins from sea krait, Laticauda semifasciata.";
RL   Toxicon 37:181-185(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=12957382; DOI=10.1016/s0378-1119(03)00637-1;
RA   Fujimi T.J., Nakajyo T., Nishimura E., Ogura E., Tsuchiya T., Tamiya T.;
RT   "Molecular evolution and diversification of snake toxin genes, revealed by
RT   analysis of intron sequences.";
RL   Gene 313:111-118(2003).
RN   [3]
RP   PROTEIN SEQUENCE OF 22-87, TOXIC DOSE, AND SUBCELLULAR LOCATION.
RC   TISSUE=Venom;
RX   PubMed=4616684; DOI=10.1042/bj1410389;
RA   Maeda N., Tamiya N.;
RT   "The primary structure of the toxin Laticauda semifasciata III, a weak and
RT   reversibly acting neurotoxin from the venom of a sea snake, Laticauda
RT   semifasciata.";
RL   Biochem. J. 141:389-400(1974).
RN   [4]
RP   FUNCTION.
RC   TISSUE=Venom;
RX   PubMed=9305882; DOI=10.1074/jbc.272.39.24279;
RA   Servent D., Winckler-Dietrich V., Hu H.-Y., Kessler P., Drevet P.,
RA   Bertrand D., Menez A.;
RT   "Only snake curaremimetic toxins with a fifth disulfide bond have high
RT   affinity for the neuronal alpha7 nicotinic receptor.";
RL   J. Biol. Chem. 272:24279-24286(1997).
RN   [5]
RP   FUNCTION.
RX   PubMed=26221036; DOI=10.1074/jbc.m115.648824;
RA   Kudryavtsev D.S., Shelukhina I.V., Son L.V., Ojomoko L.O., Kryukova E.V.,
RA   Lyukmanova E.N., Zhmak M.N., Dolgikh D.A., Ivanov I.A., Kasheverov I.E.,
RA   Starkov V.G., Ramerstorfer J., Sieghart W., Tsetlin V.I., Utkin Y.N.;
RT   "Neurotoxins from snake venoms and alpha-conotoxin ImI inhibit functionally
RT   active ionotropic gamma-aminobutyric acid (GABA) receptors.";
RL   J. Biol. Chem. 290:22747-22758(2015).
RN   [6]
RP   STRUCTURE BY NMR OF 22-87, AND DISULFIDE BONDS.
RX   PubMed=8555211; DOI=10.1021/bi9520287;
RA   Connolly P.J., Stern A.S., Hoch J.C.;
RT   "Solution structure of LSIII, a long neurotoxin from the venom of Laticauda
RT   semifasciata.";
RL   Biochemistry 35:418-426(1996).
CC   -!- FUNCTION: Binds with high affinity to muscular (tested on Torpedo
CC       marmorata, Kd=1.6 nM) and neuronal (chimeric alpha-7/CHRNA7, Kd=3 nM)
CC       nicotinic acetylcholine receptor (nAChR) and inhibits acetylcholine
CC       from binding to the receptor, thereby impairing neuromuscular and
CC       neuronal transmission (PubMed:9305882). Also shows a very weak
CC       inhibition on GABA(A) receptors (PubMed:26221036). The toxin (10 uM)
CC       inhibits 83% of current in channels composed of alpha-1-beta-3-gamma-2
CC       (GABRA1-GABRB3-GABRG2) subunits, 39% of current in channels composed of
CC       alpha-2-beta-2-gamma-2 (GABRA2-GABRB2-GABRG2) subunits, and 33% of
CC       current in channels composed of alpha-5-beta-2-gamma-2 (GABRA5-GABRB2-
CC       GABRG2) subunits (PubMed:26221036). {ECO:0000269|PubMed:26221036,
CC       ECO:0000269|PubMed:9305882}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:4616684}.
CC   -!- TISSUE SPECIFICITY: Expressed by the venom gland.
CC       {ECO:0000305|PubMed:4616684}.
CC   -!- TOXIC DOSE: LD(50) is 1.24 mg/kg by intramuscular injection.
CC       {ECO:0000269|PubMed:4616684}.
CC   -!- SIMILARITY: Belongs to the snake three-finger toxin family. Long-chain
CC       subfamily. Type II alpha-neurotoxin sub-subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC78204.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB015512; BAA32991.1; -; mRNA.
DR   EMBL; AB015513; BAA32992.1; -; mRNA.
DR   EMBL; AB098531; BAC78204.1; ALT_FRAME; Genomic_DNA.
DR   PDB; 1LSI; NMR; -; A=22-87.
DR   PDBsum; 1LSI; -.
DR   AlphaFoldDB; P01379; -.
DR   BMRB; P01379; -.
DR   SMR; P01379; -.
DR   EvolutionaryTrace; P01379; -.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0030550; F:acetylcholine receptor inhibitor activity; IEA:UniProtKB-KW.
DR   GO; GO:0099106; F:ion channel regulator activity; IEA:UniProtKB-KW.
DR   GO; GO:0090729; F:toxin activity; IEA:UniProtKB-KW.
DR   CDD; cd00206; snake_toxin; 1.
DR   Gene3D; 2.10.60.10; -; 1.
DR   InterPro; IPR003571; Snake_3FTx.
DR   InterPro; IPR045860; Snake_toxin-like_sf.
DR   InterPro; IPR018354; Snake_toxin_con_site.
DR   SUPFAM; SSF57302; SSF57302; 1.
DR   PROSITE; PS00272; SNAKE_TOXIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylcholine receptor inhibiting toxin;
KW   Direct protein sequencing; Disulfide bond; Ion channel impairing toxin;
KW   Neurotoxin; Postsynaptic neurotoxin; Secreted; Signal; Toxin.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000269|PubMed:4616684"
FT   CHAIN           22..87
FT                   /note="Alpha-elapitoxin-Ls2a"
FT                   /evidence="ECO:0000269|PubMed:4616684"
FT                   /id="PRO_0000035430"
FT   DISULFID        24..41
FT                   /evidence="ECO:0000269|PubMed:8555211,
FT                   ECO:0000312|PDB:1LSI"
FT   DISULFID        34..62
FT                   /evidence="ECO:0000269|PubMed:8555211,
FT                   ECO:0000312|PDB:1LSI"
FT   DISULFID        47..51
FT                   /evidence="ECO:0000269|PubMed:8555211,
FT                   ECO:0000312|PDB:1LSI"
FT   DISULFID        66..77
FT                   /evidence="ECO:0000269|PubMed:8555211,
FT                   ECO:0000312|PDB:1LSI"
FT   DISULFID        78..83
FT                   /evidence="ECO:0000269|PubMed:8555211,
FT                   ECO:0000312|PDB:1LSI"
FT   VARIANT         40
FT                   /note="I -> K (in LSIII-5)"
FT                   /evidence="ECO:0000269|PubMed:9920490"
FT   STRAND          24..26
FT                   /evidence="ECO:0007829|PDB:1LSI"
FT   STRAND          40..45
FT                   /evidence="ECO:0007829|PDB:1LSI"
FT   STRAND          59..65
FT                   /evidence="ECO:0007829|PDB:1LSI"
FT   STRAND          74..80
FT                   /evidence="ECO:0007829|PDB:1LSI"
FT   TURN            81..84
FT                   /evidence="ECO:0007829|PDB:1LSI"
SQ   SEQUENCE   87 AA;  9551 MW;  CECC71F4A25C50A4 CRC64;
     MKTLLLTLVV VTIVCLDLGY TRECYLNPHD TQTCPSGQEI CYVKSWCNAW CSSRGKVLEF
     GCAATCPSVN TGTEIKCCSA DKCNTYP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024